Founder & CEO, Digital Medicine Society (DiMe)

Jennifer C. Goldsack is the founder and CEO of the Digital Medicine Society (DiMe), a 501(c)(3) non-profit organization dedicated to advancing digital medicine to optimize human health. Her work centers on applied, evidence-driven approaches to the safe, effective, and equitable use of digital technologies across health, healthcare, and research.

Before founding DiMe, Jennifer helped drive progress in two digital health start-ups, including one successful exit. She also served as a senior leader at the Clinical Trials Transformation Initiative (CTTI), a public-private partnership co-founded by Duke University and the FDA. There, she led several initiatives within CTTI’s Digital Program and was the operational co-lead of the first randomized clinical trial conducted using FDA’s Sentinel System.

Earlier in her career, she spent five years conducting research at the Hospital of the University of Pennsylvania, first in the Department of Surgery’s Outcomes Research group and later in the Department of Medicine. She then helped launch the Value Institute, a pragmatic research and innovation center embedded within a large academic medical center in Delaware.

Jennifer serves on the boards of the Coalition for Health AI (CHAI) and Sage Bionetworks. She is a member of the National Academies of Sciences, Engineering, and Medicine’s Roundtable on Genomics and Precision Health, contributes to the World Economic Forum’s Digital Health Action Collaborative, and serves on the Executive Committee of the U.S. Department of Health and Human Services’ National Committee on Vital and Health Statistics (NCVHS).

She holds a master’s degree in chemistry from the University of Oxford, a master’s in the history and sociology of medicine from the University of Pennsylvania, and an MBA from the George Washington University. Jennifer is a retired elite athlete — a Pan American Games champion, Olympian, former world record holder, and World Championship silver medalist.